Latest News about VTRS
Recent news which mentions VTRS
The Best Dividend Stocks to Buy for the Fourth Quarter (and Beyond)
October 06, 2021
From Motley Fool
5 Ultra-Popular Stocks With 120% to 190% Upside, According to Wall Street
September 29, 2021
From Motley Fool
Only 47 stocks in the S&P 500 have fallen over the past year — Wall Street predicts they will climb up to 54% in 12 months
September 28, 2021
From MarketWatch
Is It Time to Buy the S&P 500's 3 Worst-Performing Stocks?
September 28, 2021
From Motley Fool
Pfizer Stock: Vaccine Crown Not Enough as Profit King Status Comes Next
September 27, 2021
From InvestorPlace
3 Top Biotech Stocks to Buy for the Long Haul
September 27, 2021
From Motley Fool
Is Now the Time to Ditch Pharma Stocks?
September 21, 2021
From Motley Fool
7 Spinoff Stocks to Buy That Are Set to Outperform Their Parents
September 17, 2021
From InvestorPlace
3 Dividend Stocks With 133% to 155% Upside, According to Wall Street
September 17, 2021
From Motley Fool
Why Are Theravance Bio Shares Plummeting Premarket Today?
September 15, 2021
From Benzinga
Why Wall Street Thinks This Dirt Cheap Value Stock Could Soar
September 13, 2021
Tickers
VTRS
From Motley Fool
3 Dividend Stocks to Buy If You're Worried About the Stock Market
September 05, 2021
From Motley Fool
4 Market-Topping Dividend Stocks That Can Double Your Money by 2026
September 04, 2021
From Motley Fool
Got $5,000? These 2 Dividend Stocks Are Dirt Cheap Buys
September 02, 2021
From Motley Fool
3 Things About Pfizer That Smart Investors Know
August 31, 2021
From Motley Fool
2 Healthcare Stocks That Could Make You Richer
August 27, 2021
From Motley Fool
Better Healthcare Stock: Johnson & Johnson vs. Pfizer
August 26, 2021
From Motley Fool
3 Boring Healthcare Stocks Everyone Should Own
August 21, 2021
From Motley Fool
3 Top Biotech Stocks to Buy in August
August 17, 2021
From Motley Fool
Analysts Love This Newly Formed Healthcare Company; Should You?
August 16, 2021
From Motley Fool
Earnings Scheduled For August 9, 2021
August 09, 2021
From Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
From Benzinga
From MarketWatch
How This Historic FDA Approval Benefits Viatris
August 04, 2021
From Motley Fool
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
